Cipher Holding Corp. Exchanges Common Shares for Convertible Debt Position of Positron Corporation.OAK BROOK, Ill. -- Cipher cipher: see cryptography. (1) The core algorithm used to encrypt data. A cipher transforms regular data (plaintext) into a coded set of data (ciphertext) that is not reversible without a key. Holding Corp. (OTCBB OTCBB See OTC Bulletin Board (OTCBB). :CIHR CIHR Canadian Institutes of Health Research CIHR Cambodian Institute of Human Rights ), announced today that the Company has acquired a secured convertible debt position in Positron positron: see antiparticle. positron Subatomic particle having the same mass as an electron but with an electric charge of +1 (an electron has a charge of −1). It constitutes the antiparticle (see antimatter) of an electron. Corporation, (OTCBB:POSC POSC Petrotechnical Open Software Corporation POSC Payroll Online Service Center (state of Maryland) POSC Personnel Occupational Specialty Code ) a U.S.-based publicly traded manufacturer of Positron Emission Tomography positron emission tomography: see PET scan. positron emission tomography (PET) Imaging technique used in diagnosis and biomedical research. (PET) scanners from IMAGIN Diagnostics Centres, Inc. a Canadian Corporation. Cipher Holding will issue 30 million common shares from its treasury for this transaction. Cipher will hold a Convertible Debt position that converts into an excess of 50% ownership of Positron Corporation. Cipher may be deemed a control holder of Positron when and if conversion of the debt position into Positron common shares should occur. Cipher Holding's strategy is to become a leading investor and developer of PET Molecular Imaging businesses. Cipher Holding will pursue development opportunities, strategic investments and acquire significant or majority owned positions in companies dedicated to PET scanning for the diagnosis of cancer, heart disease and neurological diseases. Cipher has also announced to request approval from its shareholders to change its name to "IMAGIN Molecular Corporation" and spin off its Cipher Multimedia holding to its shareholders. IMAGIN Molecular Corporation will work closely with IMAGIN Diagnostics of Canada to expand on its ability to finance and develop PET and PET related products and businesses throughout North American North American named after North America. North American blastomycosis see North American blastomycosis. North American cattle tick see boophilusannulatus. and International markets. Corey Conn, President of Cipher stated, "Cipher's new name 'IMAGIN Molecular Corporation' reflects the intention of IMAGIN to become a worldwide factor in the delivery of the benefits of PET technology to cancer, cardiac and neurology patients and their doctors, all of whom have a desire to scan the body at a molecular level in order to most effectively treat the world's most prevalent diseases". About Cipher Holding Corporation: Cipher Holding will change its name to IMAGIN Molecular Corporation to better reflect the Company's strategy and focus dedicated to business opportunities in PET manufacturing and the diagnosis of cancer, heart disease and neurological diseases. With the acquisition of the Positron convertible notes, IMAGIN Molecular Corporation has positioned the Company to be a factor in PET and ancillary molecular imaging businesses. Cipher Holding is also the Parent of Cipher Multimedia a new Media Marketing and Distribution Solution Company that provides a Distribution Solution for publishers of digital content. Cipher Multimedia will develop marketing campaigns that will assist IMAGIN, Positron and other companies market their products and will continue to provide publishers a distribution solution for digital content. About Positron Corporation: Positron Corporation is primarily engaged in designing, manufacturing, marketing and supporting advanced medical imaging devices utilizing positron emission tomography (PET) technology under the trade name POSICAM Systems. POSICAM Systems incorporate patented and proprietary technology for the diagnosis and treatment of patients in the areas of oncology, cardiology and neurology. POSICAM systems are used at leading medical facilities, including the University of Texas -- Houston Health Science Center; Hadassah Hebrew University Hospital in Jerusalem, Israel; The Coronary Disease Reversal Center in Buffalo, New York New York, state, United States New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of ; Emory Crawford Long Hospital Carlyle Fraser Heart Center in Atlanta; and Nishidai Clinic (Diagnostic Imaging Center) in Tokyo. About IMAGIN Diagnostics: IMAGIN Diagnostic Centres, Inc. is a developmental stage company dedicated to being the leader in bringing PET ("Positron Emission Tomography") and PET/CT PET/CT Positron Emission Tomography and Computed Tomography ("Computed Tomography Computed tomography (CT scan) X rays are aimed at slices of the body (by rotating equipment) and results are assembled with a computer to give a three-dimensional picture of a structure. ") technology to Canada. IMAGIN Diagnostics is affiliated with Canadian companies, which operate PET scan PET scan (pĕt) or positron emission tomography (pŏz`ĭtrŏn' ĭmĭsh`ən təmŏg`rəfē) facilities in Vancouver and Mississauga as well as early stage developmental PET center initiatives in other Canadian cities. IMAGIN Diagnostics will continue to develop its initiatives in PET scan centres and businesses across Canada targeting diagnosis and staging for cancer. Additionally, the Company plans to roll-out Cardiac PET scan centers in the United States and Canada to take advantage of Positron's unique technology for PET scanning of the heart. IMAGIN is located in Toronto, Ontario. For further information please contact the Cipher Holding Corporation at 630-371-5583 |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion